NeoGenesis Pharmaceuticals, Inc.
Director, Scientific Computing
Managed a group of developers and scientists
responsible for development and implementation of mathematical
algorithms for chemical library design, experimental data
analysis, and bioinformatics. Acquired
by Schering-Plough Corp
Delta Global Trading, L.P.
Managed a fixed-income relative
value hedge fund with US$200 million in assets under
management. Developed mathematical and computational models for
identifying and exploiting economic mispricings in sovereign debt